NMTC | NeuroOne Medical Technologies Corporation Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.6100 - 0.6300
52 Week Range	0.3950 - 1.3900
Beta	0.65
Implied Volatility	408.14%
IV Rank	100.00%
Day's Volume	98,466
Average Volume	291,681
Shares Outstanding	47,385,500
Market Cap	29,549,598
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2018-03-15

Valuation
Profitability
Growth
Health
P/E Ratio	-2.40
Forward P/E Ratio	N/A
EPS	-0.26
1YR Price Target	2.62
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	16
Country	USA
Website	NMTC

NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram(cEEG) and stereoelectrocencephalography(sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders.

NMTC's peers: BSGM, NMRD, BMRA, XAIR, MOVE, SNWV, DYNT, LNSR, NPCE, OSA, SRDX, PETV, TNON, PETVW, SSKN, NSYS, CVRX, BTCY, BBLG, DCTH, HSCS

*Chart delayed

Analyzing fundamentals for NMTC we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see NMTC Fundamentals page.

Watching at NMTC technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on NMTC Technicals page.